Chinami Nagura - Publications

Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the INFINITY Cohort.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: February 22, 2025

The prognostic value of serum hepcidin-25 in predicting cardiovascular events among maintenance hemodialysis patients: insights from the INFINITY cohort.

Journal: Clinical and experimental nephrology

Published: January 10, 2025

Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis.

Journal: Nutrients

Published: September 27, 2019

Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.

Journal: European journal of clinical nutrition

Published: July 09, 2018

Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.

Journal: Diabetes & vascular disease research

Published: June 21, 2018

The adrenal gland circadian clock exhibits a distinct phase advance in spontaneously hypertensive rats.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: April 22, 2018

Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.

Journal: American journal of nephrology

Published: March 14, 2018

Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial.

Journal: Diabetes research and clinical practice

Published: February 22, 2016